Holista Colltech Limited · ASX:HCT
Holista Colltech — Investor Presentation (November 2021)
16 slides from Holista Colltech's investor presentation, November 2021
Slide 1: Investor Presentation
Investor Presentation November 2021
Slide 2: Company Overview (ASX: HCT)
Company Overview (ASX: HCT) World-leading technologies & global reach Holista Colltech is an emerging Australian developer of unique • Successfully commercialised portfolio of patent- health and wellness products in the protected/proprietary technologies US$4.5 trillion Global Health and Wellness In
Slide 3: Year of Achievements
Year of Achievements Foundations for a stronger FY22 Signed Term Tests showing Natshield™ sheet with Natshield™ trademark Berjaya remains 1st order effective on Exclusive received for approved in Country Farms Launch “List distribution SARS-CoV-2 China skin and hard N” HVAC agreement for surfaces fo
Slide 4: Business Divisions
Business Divisions Growth engines • Fastest growing •Newest business •Largest •1st to produce Ovine Collagen Healthy Food Ingredients Infection Control Solutions Dietary Supplements division (FY20 1st year sales/profit ovine collagen • Momentum contribution) contributor from Australian expected to •
Slide 5: Food Ingredients Developments & update
Food Ingredients Developments & update Sales increased by 45% Q3 2021 v Q3 2020, driven by GI Lite™ and 80Less™ Growth driven by Costanzo’s orders despite pandemic in USA Stronger growth expected with Costanzo’s official launch in Muffins, white breads and December 2021 pasta made with GI LiteTM sco
Slide 6: Infection Control Developments & update
Infection Control Developments & update Natshield™ received Trademark approval for sales in China Persistence tests proof Natshield™ lasts up to 12 hours on skin and hard surface Launching world’s first Nasal Protecting Balm active for 12 hours in Q4 2021 in Malaysia, US and South America Securing t
Slide 7: Infection Control Natshield Nasal Protecting Balm
Infection Control Natshield™ Nasal Protecting Balm Persistence tests prove Natshield™ lasts up to 12 hours on skin and hard surface by SGS and Chemlab in Malaysia Nasal protecting balm formulated to be PH 5.5 which prevents pathogen growth on skins* Contains 5% Path-Away® / Protectene™ that has been
Slide 8: Dietary Supplements Developments & update
Dietary Supplements Developments & update Double digit growth in Sales Q3 2021 v Q3 2020 Growth driven by rebound from COVID and launch of new supplement (Hydro D – water soluble Vitamin D) “Cash Cow” business that contributed ~70% of 2021 Group revenue with market leading products Global Supplement
Slide 9: Ovine Collagen Developments & update
Ovine Collagen Developments & update World’s 1st and only company to extract ovine collagen from Australian sheep Guangzhou Sinbio Cosmetic Co Ltd is a Chinese state- owned enterprise that Production facility in Collie, Western Australia using exclusively represents patented technology to produce pr
Slide 10: Unlocking Value for Ovine Collagen
Unlocking Value for Ovine Collagen Significant growth options Grow Establish world leading collagen offering through Guangzhou Sinbio opportunity and existing customer relationships Partner Upgrade To consider developing food-grade Produce medical-grade collagen to collagen in future capitalise on l
Slide 11: Outlook
Outlook Roadmap to growth
Slide 12: Positive Outlook
Positive Outlook Improved 2022 results expected Healthy Food ✓ Multiple Growth Levers: Several • Improved demand for GI-LiteTM and 80LessTM • Growing consumer focus on healthier foods to drive growth significant growth opportunities that • Trials with Berjaya’s Country Farms ongoing can lead to a si
Slide 13: Investment Proposition
Investment Proposition Well-positioned for growth Multiple growth avenues with defensive revenue streams Global reach with proven products sold around the world $ Large addressable and growing markets in health/wellness Positive outlook with further growth momentum expected Improved results expected
Slide 14: Board of Directors & Advisors
Board of Directors & Advisors Expertise to lead the group forward Rajen Manicka Jay Stephenson Executive Chairman Walter Joseph Loren King MD & CEO Non-Executive Director Non-Executive Director Company Secretary Roscoe Moore Advisor Dr Rajen spent nine years Successful track record Mrs Loren King ha
Slide 15: Disclaimer
Disclaimer This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. The presentation is for information purposes only and does not constitute or form part of any offer or invitation
Slide 16: Thank You
To join our mailing list please email: update@holistaco.com Thank You For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com Investor/Media Relations: Brendon Lau (m: 0409 341 613, e: brendon@vantagepointpartners.com.au)
Holista Colltech — Investor Presentation (November 2021) on 6ix